Bank of America Initiates Aduro BioTech With Buy

by Monica Gerson, Benzinga Staff Writer

May 11, 2015 8:22 AM | 13 seconds read | Make a Comment

Analysts at Bank of America initiated coverage on

Aduro BioTech IncADRO

with a Buy rating. The target price for Aduro BioTech is set to $40. Aduro BioTech shares rose 1.46 percent to $31.30 in pre-market trading.

Posted In: Initiation Analyst Ratings Bank of America

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.